Related Experiment Video
Updated: Jan 18, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
G.AI.A: An Integrated Machine-Learning Platform for Predicting Bioaccumulation and Ecotoxicity of Pharmaceuticals
Evangelos Tsoukas1, Michail Papadourakis1, Eleni Chontzopoulou1
1Cloudpharm PC, Athens 15125, Greece.
None:
Pharmaceutical pollution in aquatic environments poses a significant ecological threat due to the accumulation of bioactive compounds from human and veterinary sources. In support of the EU Green Deal's Chemicals Strategy for Sustainability, this study presents a computational framework for predicting two key environmental risk indicators in fish: bioconcentration and ecotoxicity. Bioconcentration, quantified by the bioconcentration factor (BCF), reflects a chemical's tendency to accumulate in organisms, while ecotoxicity is assessed via the median lethal concentration (LC50) over defined exposure periods. We developed two high-performing machine learning (ML) models, achieving ROC AUC scores of 94.60% for bioconcentration and 96.06% for ecotoxicity, validated across both internal and external data sets. To expand the scope of risk evaluation, we incorporated metabolite prediction using the SyGMa tool, selected after benchmarking multiple alternatives. This enables the assessment of both parent compounds and their potentially toxic metabolites. Model interpretability was enhanced through molecular fingerprint analysis, which identified structural features associated with toxicity and accumulation, informing the early stages of drug design. To support practical implementation, we introduced G.AI.A (https://gaiatox.eu/), an intuitive web platform that allows users to input Simplified Molecular Input Line Entry System (SMILES) strings for rapid prediction of environmental risk end points. The application domain of G.AI.A lies in predictive toxicology, enabling researchers and regulatory bodies to assess the toxicological profiles of small organic compounds, excluding those containing heavy metals, by analyzing their chemical structures. The platform supports batch processing and offers interactive visualizations, facilitating compound screening and early stage environmental risk assessment. By integrating predictive modeling with interpretability and usability, our framework advances green-by-design pharmaceutical development and contributes to sustainable chemical management.
More Related Videos
09:01A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Physiological Pharmacokinetic Models: Assumption with Protein Binding